Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;19(3):66-69.
doi: 10.1192/bji.2022.1.

Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective

Venkata Lakshmi Narasimha  1 , J L Butner  2 , Enjeline Hanafi  3 , Mehdi Farokhnia  4 , Roshan Bhad  5 , Fatemeh Chalabianloo  6 , Christos Kouimtsidis  7 , Alexander Baldacchino  8 , Shalini Arunogiri  9
Affiliations
Review

Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective

Venkata Lakshmi Narasimha et al. BJPsych Int. 2022 Aug.

Abstract

The COVID-19 pandemic has significantly affected treatment services for people with substance use disorders (SUDs). Based on the perspectives of service providers from eight countries, we discuss the impact of the pandemic on SUD treatment services. Although many countries quickly adapted in provision of harm reduction services by changes in policy and service delivery, some went into a forced abstinence-based strategy. Similarly, disruption of abstinence-based approaches such as therapeutic communities has been reported. Global awareness is crucial for responsible management of SUDs during the pandemic, and the development of international health policy guidelines is an urgent need in this area.

Keywords: Abstinence; COVID-19; addiction; harm reduction; substance use; treatment.

PubMed Disclaimer

Conflict of interest statement

M.F. is an employee of the US Federal Government and is supported by National Institutes of Health (NIH) intramural funding (ZIA-DA000635 and ZIA-AA000218), outside of this research. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other agencies.

References

    1. Clear A, Springer E, Lanier C. The harm reduction coalition. Newsline People AIDS Coalit NY, 1998(Jun): 27–34. - PubMed
    1. Kouimtsidis C, Pauly B, Parkes T, Stockwell T, Baldacchino AM. COVID-19 social restrictions: an opportunity to re-visit the concept of harm reduction in the treatment of alcohol dependence. A position paper. Front Psychiatry 2021; 12: 623649. - PMC - PubMed
    1. Arunogiri S, Lintzeris N. Depot buprenorphine during COVID-19 in Australia: opportunities and challenges. J Subst Abuse Treat 2021; 124: 108221. - PMC - PubMed
    1. Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, et al. Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey. Front Psychiatry 2021; 12: 349. - PMC - PubMed
    1. Farhoudian A, Radfar SR, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Khojasteh Zonoozi A, et al. A global survey on changes in the supply, price, and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic. Front Psychiatry 2021; 12: 646206. - PMC - PubMed